• Compass

  Participated · Series B · Mar 2026

  Compass operates a suite of tourism-focused services that include its "Japan Wonder Travel" guided tours for inbound visitors, the accommodation management platform "COMPASS STAY," and the nationwide kimono rental chain "wargo." To build an end-to-end visitor experience, the company also provides optional tour planning, tourism consulting, and has recently expanded into transportation by fully acquiring mobility operators Cab Station and Autec—its eighth M&A transaction to date. Compass’ strategy is to create a seamless ecosystem covering lodging, transit, and activities for both domestic and international travelers. The newly raised funds will be allocated to additional M&A activity, as well as equipment, software development, and recruitment to scale its offerings. Including the latest Series B proceeds and loan, Compass has secured roughly ¥2.8 billion in total capital. The company sees these investments as a springboard to accelerate growth across its hotel operations, experiential services, and regional production businesses.

• Ubicquia

  Participated · Series D · Feb 2026

  Ubicquia builds plug-and-play hardware and software that digitize legacy urban and utility assets, enabling real-time monitoring of power quality, lighting performance, and security conditions. Core offerings include the UbiVu intelligent asset-management platform, UbiCell street-light controllers, UbiScout smart camera accessories, the UbiGrid DTM+ transformer monitor paired with a subscription-based Power Monitoring service, and the UbiHub edge processing device for public safety analytics. The company’s analytics engine processes more than 3.5 billion data sets daily and supports over 1,000 utilities and municipalities worldwide, driving a fast-growing infrastructure-as-a-service revenue model. Ubicquia’s technology is compatible with roughly 450 million streetlights, 500 million transformers, and 1 billion utility poles, giving it a vast addressable market across the U.S., Latin America, Europe, and MENA regions. Recent product launches focus on expanding AI capabilities to help customers cut energy costs, extend asset life, and improve roadway safety. Management plans to use new capital to accelerate AI development and scale direct sales domestically and internationally. Headquartered in Fort Lauderdale, the company serves a broad customer base that now includes retailers, healthcare networks, universities, and large enterprise campuses.

• OmniOps

  Led · Equity · Dec 2024

  OmniOps provides cloud and high-performance computing (HPC) solutions, specializing in sustainable, energy-efficient HPC clusters and scalable infrastructure tailored to client needs. Founded in 2024 by Mohammed Altassan and based in Riyadh, the company is developing a sovereign AI inference cluster with ML Ops features to streamline AI deployment. OmniOps collaborates with technology partners including NVIDIA and Google Cloud and serves enterprise customers such as Saudi Airlines. The company plans to use recent funding to scale operations, enhance R&D, and advance AI infrastructure offerings in Saudi Arabia. In December 2024 OmniOps secured SAR 30 million (US$8M) to support growth and product development.

• Chefaa

  Participated · Equity · Dec 2023

  Chefaa operates a patient‑focused pharmacy benefits platform that simplifies ordering, scheduling, and refilling recurring insured and non‑insured prescriptions for users and stakeholders in the healthcare chain. The company was founded in 2017 by Drs. Doaa Aref and Rasha Rady and is led by CEO Doaa Aref. Chefaa currently links over one million active users each month to more than 1,100 pharmacies across Saudi Arabia and Egypt. It is operational in eight Saudi cities following a successful launch there and is pursuing faster regional growth. The recent $5.25 million funding is intended to propel expansion and accelerate growth in Saudi Arabia. Management emphasizes designing new services and measuring Chefaa’s impact as it scales. Chefaa is an Egyptian on-demand medicine delivery platform that allows patients to order prescriptions and other products from pharmacies. The company was founded in 2017 by Dr Rasha Rady and Doaa Aref. It has launched a white-label product and plans to use new funding to grow its operations team and to launch a B2B service serving SMEs. The recently announced round was described only as a seven-figure dollar investment; the exact amount was not disclosed. Earlier funding includes investments announced in August last year from 500 Startups and Flat6Labs, and Crunchbase records $304,000 raised across two prior rounds. Vision Ventures said the investment will help expand services to improve availability of basic medicines and personal care products in the region.

• CeQur Simplicity

  Participated · Equity · Apr 2021

  CeQur commercializes simple-to-use, wearable insulin-delivery devices designed to replace multiple daily injections, with CeQur Simplicity as its mealtime insulin patch offering. The company reports clinical evidence showing significantly improved A1C and time-in-range outcomes and cites studies and presentations supporting patient adherence. Adoption is expanding across primary care and endocrinology practices; the company says better than 85% of claims are covered as a pharmacy benefit with an average copay of less than $45 per month. Nearly 90% of patients reported better adherence with CeQur Simplicity versus multiple daily injections, according to cited patient-experience data. CeQur has new FDA clearances and an advancing pipeline that includes extended 7-day wear and 1-unit and 2-unit patch options. The company announced a $100 million Series E to fund commercial expansion, including growth of its field sales organization.

No current team members are available.